Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD have?
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD has 42 citations in the OpenAlex counts ScholarIQ stores.
When was Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD published?
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD has 2025 year in the ScholarIQ index.
What is the open-access status of Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD has closed oa status in the ScholarIQ index.
What is the DOI of Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?
The DOI for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is on the source record.
What is the PMID of Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?
The PMID for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is on the source record.
What is the OpenAlex record for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD?
The OpenAlex for Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD is on the source record.